ADC Therapeutics | 4:持股变动声明-股东 Redmile Group, LLC
ADC Therapeutics | 4:持股变动声明-高管 Zaki Mohamed
ADC Therapeutics | 4:持股变动声明-高管 Kallebo Lisa Michelle
ADC Therapeutics | 4:持股变动声明-高管 Carmona Jose
ADC Therapeutics | 4:持股变动声明-高管 GRAHAM PETER J
ADC Therapeutics | 4:持股变动声明-高管 MALLIK AMEET
ADC Therapeutics | 4:持股变动声明-股东 Redmile Group, LLC
ADC Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Redmile Group, LLC(16.2%),Jeremy C. Green(16.2%)等
ADC Therapeutics | 8-K:重大事件
ADC Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Prosight Management, LP(9.95%),Prosight Partners, LLC(9.95%)等
ADC Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Prosight Management, LP(9.96%),Prosight Partners, LLC(9.96%)等
ADC Therapeutics | 10-Q:2024财年三季报
ADC Therapeutics | 8-K:ADC Therapeutics公布2024年第三季度和年初至今的财务业绩,并提供最新运营情况
ADC Therapeutics | DEFA14A:其他
ADC Therapeutics | DEF 14A:股东委托书决议
ADC Therapeutics | PRE 14A:并购重组委托声明
ADC Therapeutics | EFFECT:其他
ADC Therapeutics | CORRESP:信函
ADC Therapeutics | UPLOAD:其他
ADC Therapeutics | S-3:特定交易注册声明